MSL
UTHR icon

Mackay Shields LLC’s United Therapeutics UTHR Stock Holding History

Mackay Shields LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,595
Closed -$8.46M – 1306
2021
Q1 		$8.46M Sell
50,595
-46,868
-48% -$7.81M 0.06% 321
2020
Q4 		$14.8M Buy
97,463
+41,123
+73% +$5.4M 0.1% 228
2020
Q3 		$5.69M Sell
56,340
-23,508
-29% -$2.58M 0.04% 431
2020
Q2 		$9.66M Sell
79,848
-10,713
-12% -$1.21M 0.08% 288
2020
Q1 		$8.59M Sell
90,561
-32,215
-26% -$3.06M 0.08% 289
2019
Q4 		$10.8M Buy
122,776
+56,137
+84% +$4.94M 0.07% 304
2019
Q3 		$5.31M Buy
66,639
+26,915
+68% +$2.17M 0.03% 483
2019
Q2 		$3.1M Sell
39,724
-16,279
-29% -$1.52M 0.02% 741
2019
Q1 		$6.57M Buy
56,003
+5,783
+12% +$674K 0.05% 424
2018
Q4 		$5.47M Sell
50,220
-26,693
-35% -$3.1M 0.04% 448
2018
Q3 		$9.84M Buy
76,913
+60,451
+367% +$7.48M 0.08% 307
2018
Q2 		$1.86M Sell
16,462
-109,912
-87% -$12.1M 0.01% 787
2018
Q1 		$14.2M Buy
+126,374
New +$16.1M 0.09% 278

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Mackay Shields LLC's UTHR Position: Q2 2021 in Review

Mackay Shields LLC sold out of United Therapeutics (UTHR) in Q2 2021, closing a stake of 50,595 shares — an estimated $8.46M sold.

Mackay Shields LLC first reported a position in UTHR in Q1 2018 and held it in 13 quarters. The position peaked at $14.8M in Q4 2020. 403 funds tracked by Wall St. Rank hold UTHR as of Q2 2021.

  • Mackay Shields LLC reported no remaining United Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 50,595 United Therapeutics shares in Q2 2021, an estimated $8.46M.
  • Mackay Shields LLC first reported a position in United Therapeutics in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's United Therapeutics position peaked at $14.8M in Q4 2020.
  • 403 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.